All News

Improving culturally responsive care and practicing cultural humility can help health care providers deliver equitable care for all patients living with multiple myeloma (MM).

The full approval follows an accelerated approval from January 2023 and was based on a confirmatory trial, which found lecanemab slowed disease progression compared with placebo.

Data included in this analysis are from the Respiratory Health in Northern Europe study, and they include asthma status, asthma-like symptoms, and other respiratory symptoms.

A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence.

Investigators found no significant impact on survival, however.

Recent developments in nanoparticle-mediated cancer immunotherapy promote treatment with less toxicity.

While the final number of EOM practices will be fewer than the numbers in the OCM, the presence of Tennessee Oncology, Texas Oncology, and Northwest Medical Specialties will ensure participation of key leaders who succeeded in the OCM and have weighed in on what's needed in its replacement.

Medicare Advantage beneficiaries are struggling to find psychiatrists; the CDC plans to cut state funding for child vaccination programs; almost 50% of American faucets could contain forever chemicals.

The act was passed in 1983 and has contributed to increased research and development on treatments for rare diseases.

Individuals with serum vitamin D concentrations of approximately 55 nmol/L appeared to be at the lowest risk of chronic obstructive pulmonary disease (COPD).

Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre in Ontario, Canada, breaks down which subgroup of patients with atopic dermatitis (AD) may benefit the most from emerging therapies, as well as the advantages and disadvantages of these therapies.

Explanatory studies, conducted under tightly controlled circumstances, could hinder the integration of technology in clinical settings by underreporting key study characteristics.

Artificial intelligence may be leveraged to improve minimal residual disease measurements for patients.

Serial biopsies help explain why patients with late relapses of diffuse large B-cell lymphoma (DLBCL) fare better than those with early relapses.

Researchers linked wildfire smoke exposure during early developmental periods to earlier first use of upper respiratory medications.

In a recent study, immune-inflammatory index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were associated with infection of respiratory syncytial virus (RSV) in children.

There may be significant differences in kidney disease between individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D).

Lifesaving organ supply disruption avoided for now; approximately a quarter of the US population had not been exposed to COVID-19 by the end of 2022; Gavi will offer developing countries a new polio vaccine.

Infants who received parenteral nutrition for at least 14 days had a higher risk of retinopathy of prematurity and receiving treatment.

Two abstracts presented at the 2023 American Society of Clinical Oncology annual meeting evaluated biosimilar adoption across oncology practices and highlighted the role payers play in preventing or promoting adoption.

Although previous research has explored and documented the prevalence of stigma facing people with chronic skin conditions, less is known about how patients respond to such stigma.

Outcomes of concern for this retrospective study were eosinophilic esophagitis (EOE) mucosal biopsies, EoE diagnosis, proton pump inhibitor initiation, and recommendations being followed for repeat esophagogastroduodenoscopy.

Researchers discovered age, race, and ethnicity representation disparities in patients taking part in research on advanced renal cell carcinoma (aRCC), further exemplifying how certain groups are underrepresented in clinical studies.

Adam Colborn, JD, director of government relations at the Academy of Managed Care Pharmacy (AMCP), also explains what health systems can do to improve patient access to biosimilars.

Maternal mortality remains "unacceptably" high across all racial and ethnic groups in the US, but disproportionately affects American Indian and Alaska Native and Black individuals, according to a new study.

Outcomes for patients with this form of the disease are poor and treatment options are limited.

Measurable residual disease (MRD) can predict disease progression in patients who have acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML).

Unless all populations are represented adequately in trials, it will be hard to know if a drug works the same in all populations as it does in one specific one, explained Robert Dellavalle, MD, PhD, MSPH, of University of Colorado School of Medicine and Rocky Mountain Regional VA Medical Center.

The study's lead author said patients would experience improved quality of life due to fewer transfusions and fewer trips to the clinic to receive treatment.

This retrospective study showed that anti–interleukin-17 drug secukinumab yielded favorable results in a small group of patients with severe hidradenitis suppurativa (HS).